Art

J-GLOBAL ID：201402208845025020   Reference number：14A0516922

Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: Results of a real-life clinical study

過活動膀胱症候群の抗ムスカリン治療に対する患者満足度に影響を及ぼす要因 現実の臨床試験結果

Author (8)： AKINO Hironobu (Univ. Fukui, Fukui) ,  NAMIKI Mikio (Kanazawa Univ., Kanazawa) ,  SUZUKI Koji (Kanazawa Medical Univ., Ishikawa) ,  FUSE Hideki (Toyama Univ., Toyama, JPN) ,  KITAGAWA Yasuhide (Kanazawa Univ., Kanazawa) ,  MIYAZAWA Katsuhito (Kanazawa Medical Univ., Ishikawa) ,  FUJIUCHI Yasuyoshi (Toyama Univ., Toyama, JPN) ,  YOKOYAMA Osamu (Univ. Fukui, Fukui)
Material： International Journal of Urology  (Int J Urol)
Volume： 21  Issue： 4  Page： 389-394  Publication year： Apr. 2014 
JST Material Number： W1347A  ISSN： 0919-8172  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *Overactive bladder syndrome ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0516922&from=J-GLOBAL&jstjournalNo=W1347A") }}

JST classification (3)： Clinical application of parasympathetics  (GW05033J) ,  Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V) ,  Clinical application of drugs acting on urinary system  (GW11020C)

Substance index (1)： KRP-197

Reference (21)：

• Abrams P, Cardozo L, Fall M et al. The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Urology 2003; 61: 37-49.
• Homma Y, Paick JS, Lee JG, Kawabe K, Japanese and Korean Tolterodine Study Group. Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with overactive bladder: a randomized, placebo-controlled trial. BJU Int. 2003; 92: 741-7.
• Yu HJ, Chen FY, Huang PC, Chen TH, Chie WC, Liu CY. Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology 2006; 67: 713-18.
• Yamaguchi O, Nishizawa O, Takeda M et al. Clinical guidelines for overactive bladder. Int. J. Urol. 2009; 16: 126-42.
• Abrams P, Artibani W, Gajewski JB, Hussain I. Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures. Urology 2006; 68 (Suppl): 17-28.

Terms in the title (7)： 過活動膀胱症候群 ,  ムスカリン ,  治療 ,  患者満足度 ,  要因 ,  現実 ,  臨床試験